NCT02077348View on ClinicalTrials.gov

Metabolic Signalling in Muscle- and Adipose-tissue Following Insulin Withdrawal and Growth Hormone Injection.

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Diabetes Mellitus Type IKetoacidosis
Interventions
DRUG

Insulin withdrawal

Withdrawal of usual (evening) insulin, replaced by Insuman Rapid (10% of the amount of usual evening insulin) as a continuous IV- administration overnight until 8 o'clock on the study day.

DRUG

Norditropin

0,4 mg of GH administered at 7.05 A.M. on the study day.

Trial Locations (1)

8000

Institute of Clinical Medicine, Aarhus

All Listed Sponsors
lead

University of Aarhus

OTHER

NCT02077348 - Metabolic Signalling in Muscle- and Adipose-tissue Following Insulin Withdrawal and Growth Hormone Injection. | Biotech Hunter | Biotech Hunter